Genetic Technologies (Australia) Today
| GTG Stock | 0.12 0.01 9.09% |
Performance5 of 100
| Odds Of DistressLess than 48
|
Genetic Technologies is selling for under 0.12 as of the 4th of May 2024; that is 9.09 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.12. Genetic Technologies has 48 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Genetic Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of April 2024 and ending today, the 4th of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Genetic Technologies is entity of Australia. It is traded as Stock on AU exchange. The company has 132.22 M outstanding shares. More on Genetic Technologies
Moving together with Genetic Stock
| 0.64 | RHCPA | Ramsay Health Care | PairCorr |
Moving against Genetic Stock
| 0.55 | WOW | Woolworths | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Genetic Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Genetic Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Genetic Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) | ||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, IT, Health Care, Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Computing (View all Sectors) | ||||
Genetic Technologies' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Genetic Technologies' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Genetic Technologies' financial leverage. It provides some insight into what part of Genetic Technologies' total assets is financed by creditors.
| |||||
Genetic Technologies (GTG) is traded on Australian Securities Exchange in Australia and employs 60 people. Genetic Technologies is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genetic Technologies's market, we take the total number of its shares issued and multiply it by Genetic Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Genetic Technologies operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 132.22 M outstanding shares.
Genetic Technologies generates negative cash flow from operations
Check Genetic Technologies Probability Of Bankruptcy
Ownership AllocationGenetic Technologies secures a total of 132.22 Million outstanding shares. Genetic Technologies retains 10.32 (percent) of its outstanding shares held by insiders and 0.0 (percent) owned by outside corporations. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Genetic Ownership Details
Genetic Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Genetic Technologies jumping above the current price in 90 days from now is about 67.16%. The Genetic Technologies probability density function shows the probability of Genetic Technologies stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Genetic Technologies has a beta of -2.7775. This usually indicates as returns on its benchmark rise, returns on holding Genetic Technologies are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Genetic Technologies is expected to outperform its benchmark. Additionally, genetic Technologies has an alpha of 0.5049, implying that it can generate a 0.5 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Genetic Technologies to move above the current price in 90 days from now is about 67.16 (This Genetic Technologies probability density function shows the probability of Genetic Stock to fall within a particular range of prices over 90 days) .
Genetic Technologies Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Genetic Technologies market risk premium is the additional return an investor will receive from holding Genetic Technologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Genetic Technologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Genetic Technologies' alpha and beta are two of the key measurements used to evaluate Genetic Technologies' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.28 | |||
| Semi Deviation | 6.01 | |||
| Standard Deviation | 8.16 | |||
| Variance | 66.55 |
Genetic Stock Against Markets
Picking the right benchmark for Genetic Technologies stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Genetic Technologies stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Genetic Technologies is critical whether you are bullish or bearish towards Genetic Technologies at a given time. Please also check how Genetic Technologies' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Genetic Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Genetic Technologies Corporate Management
Elected by the shareholders, the Genetic Technologies' board of directors comprises two types of representatives: Genetic Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genetic. The board's role is to monitor Genetic Technologies' management team and ensure that shareholders' interests are well served. Genetic Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genetic Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Camilleri | Chief EasyDNA | Profile | |
| CPA BCom | Chief Secretary | Profile | |
| Bus FCI | Consultant | Profile | |
| Simon Morriss | Chief Officer | Profile | |
| Richard Allman | Chief Officer | Profile | |
| Carl BSc | Chief Officer | Profile |
How to buy Genetic Stock?
Before investing in Genetic Technologies, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Genetic Technologies. To buy Genetic Technologies stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Genetic Technologies. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Genetic Technologies stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Genetic Technologies stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Genetic Technologies stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Genetic Technologies, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Genetic Stock please use our How to Invest in Genetic Technologies guide.
Already Invested in Genetic Technologies?
The danger of trading Genetic Technologies is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Genetic Technologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Genetic Technologies. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Genetic Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Genetic Technologies is a strong investment it is important to analyze Genetic Technologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Genetic Technologies' future performance. For an informed investment choice regarding Genetic Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genetic Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Genetic Stock please use our How to Invest in Genetic Technologies guide.Note that the Genetic Technologies information on this page should be used as a complementary analysis to other Genetic Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Genetic Stock analysis
When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |